Search Our Brain Tumor Clinical Trials


BIDMC participates in a number of collaborations such as the Eastern Cooperative Oncology Group, the Radiation Therapy Oncology Group, and the American College of Surgeons Oncology Group, and is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC) — Harvard's National Cancer Institute-designated comprehensive cancer center. We collaborate extensively on clinical trials with the DF/HCC.

The Cancer Center at BIDMC is an important center of research into the safety and effectiveness of new cancer therapies. Your physician will help you evaluate whether participation in a clinical trial is appropriate for you.

The following clinical trials related to brain tumors are now available through BIDMC. Please email or call Arline Broberg at 617-975-7403 if you have questions about participating in a clinical trial.

  • Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC) - Learn More.

  • A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy STELLAR Study  - Learn More.

Updated November 2018.